NCT05385315View on ClinicalTrials.gov

Towards the Validation of a New Blood Biomarker for the Early Diagnosis of Parkinson's Disease

RecruitingOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

October 13, 2022

Primary Completion Date

October 16, 2025

Study Completion Date

December 31, 2025

Conditions
Parkinson Disease
Trial Locations (1)

38043

RECRUITING

CHU Grenoble Alpes, Grenoble

All Listed Sponsors
collaborator

Grenoble Institut des Neurosciences

OTHER

lead

University Hospital, Grenoble

OTHER

NCT05385315 - Towards the Validation of a New Blood Biomarker for the Early Diagnosis of Parkinson's Disease | Biotech Hunter | Biotech Hunter